Aprea Therapeutics, Inc.
APRECIK 0001781983 · Every Form 4 filed by insiders at this issuer.
Filings
6
Latest Mar 28, 2024
Unique insiders
4
Showing
6 of 6
Page 1
Top insiders
Most active reporters at Aprea Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Gilad Oren | OfficerDirector | 2 |
| Hamill John P. | Officer | 2 |
| HENNEMAN JOHN B III | Director | 1 |
| Seizinger Bernd R. | Director | 1 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 28, 2024 | Gilad Oren President, CEO · Director | A | 6,725 | $0.00 | $0 | |
| Mar 28, 2024 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | A | 3,365 | $0.00 | $0 | |
| Mar 14, 2024 | Gilad Oren President, CEO · Director | P | 2,000 | $7.29 | $14,580 | |
| Mar 14, 2024 | HENNEMAN JOHN B III Director | P | 6,860 | $7.29 | $50,009 | |
| Mar 14, 2024 | Seizinger Bernd R. Director | P | 6,860 | $7.29 | $50,009 | |
| Mar 14, 2024 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | P | 1,010 | $7.29 | $7,363 |
Showing 1–6 of 6
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.